As health science and medical research leap forward, remarkable medicines, therapies and diagnostic techniques continue to emerge.
Yet cancer and heart disease still claim 30 million lives around the world each year — and as many as half a billion globally are believed to be living with some form of diabetes.
Stevens Institute of Technology is bringing the new tools of technology to the fight.
Working with partners such as MIT, Stanford, Columbia, Penn and the NIH, Stevens researchers are using AI to clarify medical images and enable earlier cardiac disease diagnosis; developing promising new cancer nanotherapies; making transplants safer; investigating the processes behind Alzheimer’s disease and dementia; innovating treatments for diabetic eye disorders; revolutionizing lung and spinal cord injury rehabilitation; and much, much more.
We encourage you to learn about Stevens’ leading-edge health and medical research.
